Product information
From Health Canada
Current status:
Approved
Current status date:
2023-02-06
Product name:
NALOXONE HYDROCHLORIDE INJECTION, USP
Description:
MULTIDOSE VIAL
DIN:
02534975 Electronic product monograph is not available
Company:
EUGIA PHARMA INC.
3700 Steeles Avenue West, Suite 402
Woodbridge
Ontario
Canada
L4L 8K8
Class:
Human
Dosage form(s):
Solution
Route(s) of administration:
Intramuscular , Intravenous , Subcutaneous
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
28:10.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
V03AB15 NALOXONE
Active ingredient group (AIG) number:See footnote5
0108981002
Active ingredient(s) | Strength |
---|---|
NALOXONE HYDROCHLORIDE | 4 MG / 10 ML |